Satisfaction Assessment After Axillary Block

Satisfaction, Patient Clinical Trial

— Qual'AXI  

Official title:

Satisfaction Assessment After Axillary Brachial Plexus Block for Distal Arm Surgery

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04305847
• Other study ID #: P/2020/480
• Status: Recruiting
• Start date: September 1, 2020
• Est. completion date: January 31, 2021

Study information

• Verified date: December 2020
• Source: Centre Hospitalier Universitaire de Besancon
• Contact: Francis Berthier, MD
• Phone: 0033381218980
• Email: f1berthier[@]CHU-besancon.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Satisfaction assessment at 24 and 48 hours post operatively, after Axillary Brachial Plexus Block for Distal Arm Surgery.

Description:

Inclusion after distal Arm Surgery performed under Axillary Brachial Plexus Block. Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: January 31, 2021
• Est. primary completion date: January 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients for whom distal arm surgery was performed under Axillary Brachial Plexus Block

Exclusion Criteria:

• Refusal, inability to consent
• inability to fill self-administered survey questionnaire
• pregnancy and breastfeeding
• surgery > 2 hours
• second surgical site requiring anaesthesia or analgesia
• chronic use of analgesia (including opioids) or illegal drugs

Related Conditions & MeSH terms

• Satisfaction, Patient

Intervention

Other:
• perioperative satisfaction assessment
Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.

Locations

Country	Name	City	State
France	CHU de Besançon	Besancon

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Besancon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evan-LR score on day 2	self administrated Evan-LR: "Evaluation du Vécu de l'Anesthésie LocoRégionale" 0-to-100 scale, with "100" indicating the best possible level of satisfaction and "0" the worst.	at 48 hours postoperative
Secondary	Evan-LR score on day 1	self administrated Evan-LR: "Evaluation du Vécu de l'Anesthésie LocoRégionale" 0-to-100 scale, with "100" indicating the best possible level of satisfaction and "0" the worst.	at 24 hours postoperative
Secondary	Net Promotor score on day 2	self administrated Net Promotor score: willingness to advise a relative to undergo the same operation on a scale from 0 to 10. Based on the score, patients are divided into promoters (9 or 10), passives (7 or 8), and detractors (under 6). The NPS is determined as follows: NPS = % promoters - % detractors	at 48 hours postoperative
Secondary	Net Promotor score on day 1	self administrated Net Promotor score: willingness to advise a relative to undergo the same operation on a scale from 0 to 10. Based on the score, patients are divided into promoters (9 or 10), passives (7 or 8), and detractors (under 6). The NPS is determined as follows: NPS = % promoters - % detractors	at 24 hours postoperative
Secondary	Patient Satisfaction score on day 2	self administrated Satisfaction score: scale from 0 to 10. A score of "0" meant extremely dissatisfied and that a score of "10" meant extremely satisfied	at 48 hours postoperative
Secondary	Patient Satisfaction score on day 1	self administrated Satisfaction score: scale from 0 to 10. A score of "0" meant extremely dissatisfied and that a score of "10" meant extremely satisfied	at 24 hours postoperative